Newman Kurt Douglas 4

What Happened
Director Kurt Newman received a grant of 7,196 restricted shares of Pediatrix Medical Group, Inc. (MD) on May 7, 2026. The Form 4 reports the award as an acquisition (code A) at $0.00 per share (grant value reported as $0). These are restricted shares awarded under the Issuer's Amended and Restated 2008 Incentive Compensation Plan as the company's annual equity award.

Key Details

• Transaction date: May 7, 2026; Form 4 filed May 11, 2026. Filing occurred four days after the transaction (Form 4s are normally due within two business days).
• Transaction type/code: Award/Grant (A). Reported acquisition price: $0.00; reported acquisition amount: 7,196 shares.
• Vesting: Shares will vest on May 7, 2027 (per footnote).
• Shares owned after transaction: Not provided in the information supplied here.
• Plan/footnote: Awarded under the company’s Amended and Restated 2008 Incentive Compensation Plan as the annual equity award.

Context
This is an equity award (restricted stock) that vests in one year; it is not an open-market purchase or sale. Restricted awards are common as part of director compensation and do not by themselves indicate a buy or sell signal—value is realized only upon vesting (and any subsequent sale). The later filing date may be worth noting for compliance tracking but does not change the nature of the award.